Active13634184Private limited companyOakham

CARDIATEC BIOSCIENCES LTD

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Cardiatec Biosciences Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Cardiatec Biosciences Ltd sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

CARDIATEC BIOSCIENCES LTD is an active private limited company (company number 13634184) incorporated on 21 September 2021, registered in Oakham. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £3.50m and cash of £3.21m, with 7 employees on average. Net assets fell 32% on the prior period (£5.17m).

Peer position · net assets

By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).

02

Ownership and control

0 active · 6 other

No active person with significant control is registered.

  • persons with significant control statement · since 11 June 2024
  • Raphael Peralta
    Individual · since 21 September 2021 · ceased 7 June 2024
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Mr Namshik Han
    Individual · since 17 March 2022 · ceased 29 March 2024
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Ms Thelma Zablocki
    Individual · since 17 March 2022 · ceased 29 March 2024
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • persons with significant control statement · since 25 March 2022 · ceased 23 March 2022
  • persons with significant control statement · since 25 March 2022 · ceased 23 March 2022

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
21 September 20215 yrs ago
Next accounts due
30 September 2027in 339 days
Confirmation statement due
5 October 2027in 344 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 December 2025
Net assets
£3.50m
−32%vs Dec 2024
Cash at bank
£3.21m
−36%vs Dec 2024
Turnover
Not reported
Employees
7
+17%vs Dec 2024
Net assets
£3.50m
Cash at bank
£3.21m
Average employees
7
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2025£3.50m£3.21m£486k———7
31 December 2024£5.17m£4.99m£204k———6
Cash per employee£458kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £3,504,164 at 31 December 2025
  • Net assets down 25% or more on the prior period-32.2% vs prior period
  • Cash at bank of £50,000 or moreCash £3,209,176
  • Incorporated five or more years agoIncorporated 21 September 2021

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 344 days
  2. Next accounts duein 339 days
  3. Accounts period endNet assets £3.50m · small accounts
  4. Accounts period endNet assets £5.17m · small accounts
  5. Incorporated
08

Similar companies in Leicester

Same activity (research and experimental development on biotechnology), closest in incorporation date
09

Reminders for CARDIATEC BIOSCIENCES LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.